Argenx Se ARGX
NASDAQ ARGX
$962.22 +16.40 (+1.73%)
At close: Sep 24, 2026 · 4:00 PM EDT

Argenx Se (ARGX) Total Current Liabilities (2015 - 2026)

Argenx Se's (ARGX) quarterly Total Current Liabilities came in at $1.6 billion in Q2 2026, down 99.85% on a YoY basis from $1041.9 billion in Q2 2025, and up 19.32% quarter-over-quarter from $1.3 billion in Q4 2025.

Analysis

Argenx Se (ARGX) Total Current Liabilities (2015 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Total Current Liabilities for 12 consecutive years, with $1.6 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Current Liabilities fell 99.85% year-over-year to $1.6 billion; the trailing twelve-month figure through Jun 2026 stood at $1.6 billion (down 99.85% YoY), and the FY2025 full-year result was $1.3 billion, down 99.8% from the prior year.
  • Total Current Liabilities improved to $1.6 billion in Q2 2026 per ARGX's latest filing, from $1.3 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $1041.9 billion in Q2 2025 and bottomed at $264.6 million in Q2 2022.
  • Historically, Total Current Liabilities has averaged $224.3 billion across 5 years, with a median of $1.3 billion in 2025.
  • The sharpest annual moves came in 2023 and 2025: Total Current Liabilities plunged 99.86% in 2023, then surged 208435.53% in 2025.
  • Over 5 years, Total Current Liabilities stood at $302.3 billion in 2022, then slumped by 99.86% to $423.0 million in 2023, then surged by 158275.2% to $669.9 billion in 2024, then tumbled by 99.8% to $1.3 billion in 2025, then climbed by 19.32% to $1.6 billion in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $1.6 billion, $1.3 billion, and $1041.9 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 54.90 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 41.64 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -31.55 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 11.02 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 3.94 Bn
10 Argenx Se 58.53 Bn 53.35 Bn 1.37 Bn 1.58 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.58 Bn
Dec 31, 2025 1.32 Bn
Jun 30, 2025 1,041.90 Bn
Dec 31, 2024 669.92 Bn
Jun 30, 2024 499.63 Mn
Dec 31, 2023 422.99 Mn
Jun 30, 2023 317.79 Mn
Dec 31, 2022 302.28 Bn
Jun 30, 2022 264.60 Mn
Dec 31, 2021 301.24 Bn
Jun 30, 2021 244.04 Mn
Dec 31, 2020 319.17 Bn
Jun 30, 2020 217.90 Mn
Dec 31, 2019 177.05 Mn
Jun 30, 2019 115.05 Mn
Dec 31, 2018 45.72 Mn
Jun 30, 2018 32.26 Mn
Dec 31, 2017 28.87 Mn
Jun 30, 2017 38.74 Mn
Dec 31, 2016 34.90 Mn
API Access

Argenx Se Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ARGX&period=max&api_key=YOUR_API_KEY